rs2166337
Variant names: 
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001369.3(DNAH5):c.13724-35T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.544 in 1,611,270 control chromosomes in the GnomAD database, including 239,576 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
 Genomes: 𝑓 0.55   (  22763   hom.,  cov: 31) 
 Exomes 𝑓:  0.54   (  216813   hom.  ) 
Consequence
 DNAH5
NM_001369.3 intron
NM_001369.3 intron
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  -0.192  
Publications
11 publications found 
Genes affected
 DNAH5  (HGNC:2950):  (dynein axonemal heavy chain 5) This gene encodes a dynein protein, which is part of a microtubule-associated motor protein complex consisting of heavy, light, and intermediate chains. This protein is an axonemal heavy chain dynein. It functions as a force-generating protein with ATPase activity, whereby the release of ADP is thought to produce the force-producing power stroke. Mutations in this gene cause primary ciliary dyskinesia type 3, as well as Kartagener syndrome, which are both diseases due to ciliary defects. [provided by RefSeq, Oct 2009] 
DNAH5 Gene-Disease associations (from GenCC):
- primary ciliary dyskinesia 3Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P, ClinGen
 - primary ciliary dyskinesiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83). 
BP6
Variant 5-13692170-A-T is Benign according to our data. Variant chr5-13692170-A-T is described in ClinVar as Benign. ClinVar VariationId is 258001.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.557  is higher than 0.05. 
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| DNAH5 | ENST00000265104.5  | c.13724-35T>A | intron_variant | Intron 78 of 78 | 1 | NM_001369.3 | ENSP00000265104.4 | |||
| DNAH5 | ENST00000681290.1  | c.13679-35T>A | intron_variant | Intron 78 of 78 | ENSP00000505288.1 | |||||
| DNAH5 | ENST00000683611.1  | n.1057-35T>A | intron_variant | Intron 4 of 4 | 
Frequencies
GnomAD3 genomes   AF:  0.545  AC: 82803AN: 151900Hom.:  22737  Cov.: 31 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
82803
AN: 
151900
Hom.: 
Cov.: 
31
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.523  AC: 128841AN: 246408 AF XY:  0.518   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
128841
AN: 
246408
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.543  AC: 793072AN: 1459252Hom.:  216813  Cov.: 33 AF XY:  0.540  AC XY: 391790AN XY: 725950 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
793072
AN: 
1459252
Hom.: 
Cov.: 
33
 AF XY: 
AC XY: 
391790
AN XY: 
725950
show subpopulations 
African (AFR) 
 AF: 
AC: 
18527
AN: 
33410
American (AMR) 
 AF: 
AC: 
22693
AN: 
44610
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
14127
AN: 
26094
East Asian (EAS) 
 AF: 
AC: 
16223
AN: 
39542
South Asian (SAS) 
 AF: 
AC: 
37591
AN: 
86118
European-Finnish (FIN) 
 AF: 
AC: 
28848
AN: 
53296
Middle Eastern (MID) 
 AF: 
AC: 
2915
AN: 
5652
European-Non Finnish (NFE) 
 AF: 
AC: 
619859
AN: 
1110228
Other (OTH) 
 AF: 
AC: 
32289
AN: 
60302
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.483 
Heterozygous variant carriers
 0 
 18243 
 36486 
 54729 
 72972 
 91215 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 17376 
 34752 
 52128 
 69504 
 86880 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome   AF:  0.545  AC: 82891AN: 152018Hom.:  22763  Cov.: 31 AF XY:  0.540  AC XY: 40112AN XY: 74332 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
82891
AN: 
152018
Hom.: 
Cov.: 
31
 AF XY: 
AC XY: 
40112
AN XY: 
74332
show subpopulations 
African (AFR) 
 AF: 
AC: 
23339
AN: 
41438
American (AMR) 
 AF: 
AC: 
8005
AN: 
15280
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
1926
AN: 
3470
East Asian (EAS) 
 AF: 
AC: 
2319
AN: 
5158
South Asian (SAS) 
 AF: 
AC: 
2115
AN: 
4820
European-Finnish (FIN) 
 AF: 
AC: 
5768
AN: 
10582
Middle Eastern (MID) 
 AF: 
AC: 
154
AN: 
292
European-Non Finnish (NFE) 
 AF: 
AC: 
37561
AN: 
67958
Other (OTH) 
 AF: 
AC: 
1168
AN: 
2108
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.504 
Heterozygous variant carriers
 0 
 1947 
 3895 
 5842 
 7790 
 9737 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 720 
 1440 
 2160 
 2880 
 3600 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
1674
AN: 
3478
ClinVar
Significance: Benign 
Submissions summary: Benign:5 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
not provided    Benign:2 
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Nov 11, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Primary ciliary dyskinesia 3    Benign:2 
Jun 15, 2021
Pars Genome Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified    Benign:1 
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.